0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet OTC Medication Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19I13081
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pet OTC Medication Market Research Report 2023
BUY CHAPTERS

Global Pet OTC Medication Market Research Report 2025

Code: QYRE-Auto-19I13081
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet OTC Medication Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Pet OTC Medication Market

Pet OTC Medication Market

The global market for Pet OTC Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 51%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet OTC Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet OTC Medication.
The Pet OTC Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet OTC Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet OTC Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pet OTC Medication Market Report

Report Metric Details
Report Name Pet OTC Medication Market
Accounted market size in 2021 $ 38.3 billion
Base Year 2021
Segment by Type
  • Tablets
  • Capsules
  • Sprays
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer AG, Boehringer Ingelheim International GmbH, Covetrus, Dechra Pharmaceuticals, Elanco Animal Health, Heska, IDEXX Laboratories, Kyoritsu Seiyaku, Merck & Co., Phibro Animal Health, Sequent Scientific, Vetoquinol SA, Virbac SA, Zoetis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pet OTC Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pet OTC Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Pet OTC Medication Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet OTC Medication Market report?

Ans: The main players in the Pet OTC Medication Market are Bayer AG, Boehringer Ingelheim International GmbH, Covetrus, Dechra Pharmaceuticals, Elanco Animal Health, Heska, IDEXX Laboratories, Kyoritsu Seiyaku, Merck & Co., Phibro Animal Health, Sequent Scientific, Vetoquinol SA, Virbac SA, Zoetis

What are the Application segmentation covered in the Pet OTC Medication Market report?

Ans: The Applications covered in the Pet OTC Medication Market report are Pet Specialty Stores, Veterinary Clinics, Others

What are the Type segmentation covered in the Pet OTC Medication Market report?

Ans: The Types covered in the Pet OTC Medication Market report are Tablets, Capsules, Sprays

Recommended Reports

Veterinary Pharmaceuticals

Pet Nutrition & Food

Veterinary Equipment

1 Pet OTC Medication Market Overview
1.1 Product Definition
1.2 Pet OTC Medication by Type
1.2.1 Global Pet OTC Medication Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Sprays
1.3 Pet OTC Medication by Application
1.3.1 Global Pet OTC Medication Market Value by Application (2024 VS 2031)
1.3.2 Pet Specialty Stores
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Global Pet OTC Medication Market Size Estimates and Forecasts
1.4.1 Global Pet OTC Medication Revenue 2020-2031
1.4.2 Global Pet OTC Medication Sales 2020-2031
1.4.3 Global Pet OTC Medication Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pet OTC Medication Market Competition by Manufacturers
2.1 Global Pet OTC Medication Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pet OTC Medication Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pet OTC Medication Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pet OTC Medication, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet OTC Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet OTC Medication, Product Type & Application
2.7 Global Key Manufacturers of Pet OTC Medication, Date of Enter into This Industry
2.8 Global Pet OTC Medication Market Competitive Situation and Trends
2.8.1 Global Pet OTC Medication Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pet OTC Medication Players Market Share by Revenue
2.8.3 Global Pet OTC Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pet OTC Medication Market Scenario by Region
3.1 Global Pet OTC Medication Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pet OTC Medication Sales by Region: 2020-2031
3.2.1 Global Pet OTC Medication Sales by Region: 2020-2025
3.2.2 Global Pet OTC Medication Sales by Region: 2026-2031
3.3 Global Pet OTC Medication Revenue by Region: 2020-2031
3.3.1 Global Pet OTC Medication Revenue by Region: 2020-2025
3.3.2 Global Pet OTC Medication Revenue by Region: 2026-2031
3.4 North America Pet OTC Medication Market Facts & Figures by Country
3.4.1 North America Pet OTC Medication Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pet OTC Medication Sales by Country (2020-2031)
3.4.3 North America Pet OTC Medication Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet OTC Medication Market Facts & Figures by Country
3.5.1 Europe Pet OTC Medication Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pet OTC Medication Sales by Country (2020-2031)
3.5.3 Europe Pet OTC Medication Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet OTC Medication Market Facts & Figures by Region
3.6.1 Asia Pacific Pet OTC Medication Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pet OTC Medication Sales by Region (2020-2031)
3.6.3 Asia Pacific Pet OTC Medication Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pet OTC Medication Market Facts & Figures by Country
3.7.1 Latin America Pet OTC Medication Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pet OTC Medication Sales by Country (2020-2031)
3.7.3 Latin America Pet OTC Medication Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet OTC Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet OTC Medication Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pet OTC Medication Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pet OTC Medication Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet OTC Medication Sales by Type (2020-2031)
4.1.1 Global Pet OTC Medication Sales by Type (2020-2025)
4.1.2 Global Pet OTC Medication Sales by Type (2026-2031)
4.1.3 Global Pet OTC Medication Sales Market Share by Type (2020-2031)
4.2 Global Pet OTC Medication Revenue by Type (2020-2031)
4.2.1 Global Pet OTC Medication Revenue by Type (2020-2025)
4.2.2 Global Pet OTC Medication Revenue by Type (2026-2031)
4.2.3 Global Pet OTC Medication Revenue Market Share by Type (2020-2031)
4.3 Global Pet OTC Medication Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pet OTC Medication Sales by Application (2020-2031)
5.1.1 Global Pet OTC Medication Sales by Application (2020-2025)
5.1.2 Global Pet OTC Medication Sales by Application (2026-2031)
5.1.3 Global Pet OTC Medication Sales Market Share by Application (2020-2031)
5.2 Global Pet OTC Medication Revenue by Application (2020-2031)
5.2.1 Global Pet OTC Medication Revenue by Application (2020-2025)
5.2.2 Global Pet OTC Medication Revenue by Application (2026-2031)
5.2.3 Global Pet OTC Medication Revenue Market Share by Application (2020-2031)
5.3 Global Pet OTC Medication Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Company Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer AG Pet OTC Medication Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Boehringer Ingelheim International GmbH
6.2.1 Boehringer Ingelheim International GmbH Company Information
6.2.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.2.3 Boehringer Ingelheim International GmbH Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim International GmbH Pet OTC Medication Product Portfolio
6.2.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.3 Covetrus
6.3.1 Covetrus Company Information
6.3.2 Covetrus Description and Business Overview
6.3.3 Covetrus Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Covetrus Pet OTC Medication Product Portfolio
6.3.5 Covetrus Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Company Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dechra Pharmaceuticals Pet OTC Medication Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Elanco Animal Health
6.5.1 Elanco Animal Health Company Information
6.5.2 Elanco Animal Health Description and Business Overview
6.5.3 Elanco Animal Health Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Animal Health Pet OTC Medication Product Portfolio
6.5.5 Elanco Animal Health Recent Developments/Updates
6.6 Heska
6.6.1 Heska Company Information
6.6.2 Heska Description and Business Overview
6.6.3 Heska Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Heska Pet OTC Medication Product Portfolio
6.6.5 Heska Recent Developments/Updates
6.7 IDEXX Laboratories
6.7.1 IDEXX Laboratories Company Information
6.7.2 IDEXX Laboratories Description and Business Overview
6.7.3 IDEXX Laboratories Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.7.4 IDEXX Laboratories Pet OTC Medication Product Portfolio
6.7.5 IDEXX Laboratories Recent Developments/Updates
6.8 Kyoritsu Seiyaku
6.8.1 Kyoritsu Seiyaku Company Information
6.8.2 Kyoritsu Seiyaku Description and Business Overview
6.8.3 Kyoritsu Seiyaku Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kyoritsu Seiyaku Pet OTC Medication Product Portfolio
6.8.5 Kyoritsu Seiyaku Recent Developments/Updates
6.9 Merck & Co.
6.9.1 Merck & Co. Company Information
6.9.2 Merck & Co. Description and Business Overview
6.9.3 Merck & Co. Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck & Co. Pet OTC Medication Product Portfolio
6.9.5 Merck & Co. Recent Developments/Updates
6.10 Phibro Animal Health
6.10.1 Phibro Animal Health Company Information
6.10.2 Phibro Animal Health Description and Business Overview
6.10.3 Phibro Animal Health Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Phibro Animal Health Pet OTC Medication Product Portfolio
6.10.5 Phibro Animal Health Recent Developments/Updates
6.11 Sequent Scientific
6.11.1 Sequent Scientific Company Information
6.11.2 Sequent Scientific Description and Business Overview
6.11.3 Sequent Scientific Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sequent Scientific Pet OTC Medication Product Portfolio
6.11.5 Sequent Scientific Recent Developments/Updates
6.12 Vetoquinol SA
6.12.1 Vetoquinol SA Company Information
6.12.2 Vetoquinol SA Description and Business Overview
6.12.3 Vetoquinol SA Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vetoquinol SA Pet OTC Medication Product Portfolio
6.12.5 Vetoquinol SA Recent Developments/Updates
6.13 Virbac SA
6.13.1 Virbac SA Company Information
6.13.2 Virbac SA Description and Business Overview
6.13.3 Virbac SA Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Virbac SA Pet OTC Medication Product Portfolio
6.13.5 Virbac SA Recent Developments/Updates
6.14 Zoetis
6.14.1 Zoetis Company Information
6.14.2 Zoetis Description and Business Overview
6.14.3 Zoetis Pet OTC Medication Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Zoetis Pet OTC Medication Product Portfolio
6.14.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet OTC Medication Industry Chain Analysis
7.2 Pet OTC Medication Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet OTC Medication Production Mode & Process Analysis
7.4 Pet OTC Medication Sales and Marketing
7.4.1 Pet OTC Medication Sales Channels
7.4.2 Pet OTC Medication Distributors
7.5 Pet OTC Medication Customer Analysis
8 Pet OTC Medication Market Dynamics
8.1 Pet OTC Medication Industry Trends
8.2 Pet OTC Medication Market Drivers
8.3 Pet OTC Medication Market Challenges
8.4 Pet OTC Medication Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pet OTC Medication Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pet OTC Medication Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pet OTC Medication Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pet OTC Medication Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pet OTC Medication Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pet OTC Medication Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pet OTC Medication Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pet OTC Medication Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pet OTC Medication, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pet OTC Medication, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pet OTC Medication, Product Type & Application
 Table 12. Global Key Manufacturers of Pet OTC Medication, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pet OTC Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet OTC Medication as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pet OTC Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pet OTC Medication Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pet OTC Medication Sales Market Share by Region (2020-2025)
 Table 19. Global Pet OTC Medication Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pet OTC Medication Sales Market Share by Region (2026-2031)
 Table 21. Global Pet OTC Medication Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pet OTC Medication Revenue Market Share by Region (2020-2025)
 Table 23. Global Pet OTC Medication Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pet OTC Medication Revenue Market Share by Region (2026-2031)
 Table 25. North America Pet OTC Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pet OTC Medication Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pet OTC Medication Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pet OTC Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pet OTC Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pet OTC Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pet OTC Medication Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pet OTC Medication Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pet OTC Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pet OTC Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pet OTC Medication Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pet OTC Medication Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pet OTC Medication Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pet OTC Medication Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pet OTC Medication Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pet OTC Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pet OTC Medication Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pet OTC Medication Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pet OTC Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pet OTC Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pet OTC Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pet OTC Medication Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pet OTC Medication Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pet OTC Medication Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pet OTC Medication Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pet OTC Medication Sales (K Units) by Type (2020-2025)
 Table 51. Global Pet OTC Medication Sales (K Units) by Type (2026-2031)
 Table 52. Global Pet OTC Medication Sales Market Share by Type (2020-2025)
 Table 53. Global Pet OTC Medication Sales Market Share by Type (2026-2031)
 Table 54. Global Pet OTC Medication Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pet OTC Medication Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pet OTC Medication Revenue Market Share by Type (2020-2025)
 Table 57. Global Pet OTC Medication Revenue Market Share by Type (2026-2031)
 Table 58. Global Pet OTC Medication Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pet OTC Medication Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pet OTC Medication Sales (K Units) by Application (2020-2025)
 Table 61. Global Pet OTC Medication Sales (K Units) by Application (2026-2031)
 Table 62. Global Pet OTC Medication Sales Market Share by Application (2020-2025)
 Table 63. Global Pet OTC Medication Sales Market Share by Application (2026-2031)
 Table 64. Global Pet OTC Medication Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pet OTC Medication Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pet OTC Medication Revenue Market Share by Application (2020-2025)
 Table 67. Global Pet OTC Medication Revenue Market Share by Application (2026-2031)
 Table 68. Global Pet OTC Medication Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pet OTC Medication Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer AG Company Information
 Table 71. Bayer AG Description and Business Overview
 Table 72. Bayer AG Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer AG Pet OTC Medication Product
 Table 74. Bayer AG Recent Developments/Updates
 Table 75. Boehringer Ingelheim International GmbH Company Information
 Table 76. Boehringer Ingelheim International GmbH Description and Business Overview
 Table 77. Boehringer Ingelheim International GmbH Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim International GmbH Pet OTC Medication Product
 Table 79. Boehringer Ingelheim International GmbH Recent Developments/Updates
 Table 80. Covetrus Company Information
 Table 81. Covetrus Description and Business Overview
 Table 82. Covetrus Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Covetrus Pet OTC Medication Product
 Table 84. Covetrus Recent Developments/Updates
 Table 85. Dechra Pharmaceuticals Company Information
 Table 86. Dechra Pharmaceuticals Description and Business Overview
 Table 87. Dechra Pharmaceuticals Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Dechra Pharmaceuticals Pet OTC Medication Product
 Table 89. Dechra Pharmaceuticals Recent Developments/Updates
 Table 90. Elanco Animal Health Company Information
 Table 91. Elanco Animal Health Description and Business Overview
 Table 92. Elanco Animal Health Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Elanco Animal Health Pet OTC Medication Product
 Table 94. Elanco Animal Health Recent Developments/Updates
 Table 95. Heska Company Information
 Table 96. Heska Description and Business Overview
 Table 97. Heska Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Heska Pet OTC Medication Product
 Table 99. Heska Recent Developments/Updates
 Table 100. IDEXX Laboratories Company Information
 Table 101. IDEXX Laboratories Description and Business Overview
 Table 102. IDEXX Laboratories Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. IDEXX Laboratories Pet OTC Medication Product
 Table 104. IDEXX Laboratories Recent Developments/Updates
 Table 105. Kyoritsu Seiyaku Company Information
 Table 106. Kyoritsu Seiyaku Description and Business Overview
 Table 107. Kyoritsu Seiyaku Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Kyoritsu Seiyaku Pet OTC Medication Product
 Table 109. Kyoritsu Seiyaku Recent Developments/Updates
 Table 110. Merck & Co. Company Information
 Table 111. Merck & Co. Description and Business Overview
 Table 112. Merck & Co. Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Merck & Co. Pet OTC Medication Product
 Table 114. Merck & Co. Recent Developments/Updates
 Table 115. Phibro Animal Health Company Information
 Table 116. Phibro Animal Health Description and Business Overview
 Table 117. Phibro Animal Health Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Phibro Animal Health Pet OTC Medication Product
 Table 119. Phibro Animal Health Recent Developments/Updates
 Table 120. Sequent Scientific Company Information
 Table 121. Sequent Scientific Description and Business Overview
 Table 122. Sequent Scientific Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sequent Scientific Pet OTC Medication Product
 Table 124. Sequent Scientific Recent Developments/Updates
 Table 125. Vetoquinol SA Company Information
 Table 126. Vetoquinol SA Description and Business Overview
 Table 127. Vetoquinol SA Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Vetoquinol SA Pet OTC Medication Product
 Table 129. Vetoquinol SA Recent Developments/Updates
 Table 130. Virbac SA Company Information
 Table 131. Virbac SA Description and Business Overview
 Table 132. Virbac SA Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Virbac SA Pet OTC Medication Product
 Table 134. Virbac SA Recent Developments/Updates
 Table 135. Zoetis Company Information
 Table 136. Zoetis Description and Business Overview
 Table 137. Zoetis Pet OTC Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Zoetis Pet OTC Medication Product
 Table 139. Zoetis Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Pet OTC Medication Distributors List
 Table 143. Pet OTC Medication Customers List
 Table 144. Pet OTC Medication Market Trends
 Table 145. Pet OTC Medication Market Drivers
 Table 146. Pet OTC Medication Market Challenges
 Table 147. Pet OTC Medication Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pet OTC Medication
 Figure 2. Global Pet OTC Medication Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet OTC Medication Market Share by Type: 2024 & 2031
 Figure 4. Tablets Product Picture
 Figure 5. Capsules Product Picture
 Figure 6. Sprays Product Picture
 Figure 7. Global Pet OTC Medication Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pet OTC Medication Market Share by Application: 2024 & 2031
 Figure 9. Pet Specialty Stores
 Figure 10. Veterinary Clinics
 Figure 11. Others
 Figure 12. Global Pet OTC Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pet OTC Medication Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pet OTC Medication Sales (2020-2031) & (K Units)
 Figure 15. Global Pet OTC Medication Average Price (US$/Unit) & (2020-2031)
 Figure 16. Pet OTC Medication Report Years Considered
 Figure 17. Pet OTC Medication Sales Share by Manufacturers in 2024
 Figure 18. Global Pet OTC Medication Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pet OTC Medication Players: Market Share by Revenue in Pet OTC Medication in 2024
 Figure 20. Pet OTC Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pet OTC Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pet OTC Medication Sales Market Share by Country (2020-2031)
 Figure 23. North America Pet OTC Medication Revenue Market Share by Country (2020-2031)
 Figure 24. United States Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pet OTC Medication Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pet OTC Medication Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pet OTC Medication Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pet OTC Medication Revenue Market Share by Region (2020-2031)
 Figure 35. China Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pet OTC Medication Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pet OTC Medication Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pet OTC Medication Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pet OTC Medication Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pet OTC Medication Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pet OTC Medication by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pet OTC Medication by Type (2020-2031)
 Figure 54. Global Pet OTC Medication Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pet OTC Medication by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pet OTC Medication by Application (2020-2031)
 Figure 57. Global Pet OTC Medication Price (US$/Unit) by Application (2020-2031)
 Figure 58. Pet OTC Medication Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS